Bristol-Myers Squibb (BMY) Announces FDA, EMA Acceptance of Opdivo Apps for Usage in SCCHN
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced today U.S. and European marketing applications to expand the use of Opdivo for patients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE